PsAPASH: A new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition Rosita Saraceno, MD, Graziella Babino, MD, Andrea Chiricozzi, MD, Arianna Zangrilli, MD, Sergio Chimenti, MD Journal of the American Academy of Dermatology Volume 72, Issue 1, Pages e42-e44 (January 2015) DOI: 10.1016/j.jaad.2014.10.002 Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Clinical details of PsAPASH syndrome. Hidradenitis suppurativa: scarring and multiple interconnected painful lesions localized at the axillae (Hurley stage II) (A). Ulcerative lesions localized at the lower extremities clinically and histologically diagnosed as pyoderma gangrenosum (B). Journal of the American Academy of Dermatology 2015 72, e42-e44DOI: (10.1016/j.jaad.2014.10.002) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions